#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic carcinoma Sjogren's syndrome Immune-mediated renal disorder Atypical haemolytic uraemic syndrome Epilepsy Malignant fibrous histiocytoma Mitochondrial encephalomyopathy Ataxia telangiectasia Anti-neutrophil cytoplasmic antibody positive vasculitis Lung adenocarcinoma Hyperinsulinism Macular telangiectasia Congenital ectodermal dysplasia Hereditary hypophosphataemic rickets Glomerulonephritis More trials…

    Learn about Rare Diseases

    Rett syndrome – Treatment Systemic mastocytosis Usher’s syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis Nephroblastoma – Life with Disease Usher’s syndrome – Diagnostics Turner’s syndrome – Diagnostics Idiopathic pulmonary fibrosis – Treatment Marginal zone lymphoma – Treatment Glomerulonephritis membranoproliferative – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludarabine Indocyanine Green Tebipenem Pivoxil Hydrobromide Epinephrine Bitartrate Ro7589655 Db-1303 IMELASOMERAN Nelarabine Leuprorelin Acetate Difelikefalin Gefurulimab Ketoprofen Antiemetics And Antinauseants Tominersen Camizestrant OSIMERTINIB MESYLATE Rbl035.2 Omalizumab Reboxetine Capmatinib More therapies…

    Learn about Your Condition

    Parkinson's disease Cystic fibrosis lung Influenza B-cell lymphoma refractory Endocrine ophthalmopathy Neurodermatitis Obstructive airways disorder Neurodevelopmental disorder Extra-osseous Ewing's sarcoma Prader-Willi syndrome Head and neck cancer stage III Hyperthyroidism Childhood asthma Hairy cell leukaemia recurrent Plasma cell myeloma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bromocriptine
    • Colesevelam
    • Dimeticone
    Belgium France Germany Romania

  • Study of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Ivosidenib
    Austria Germany The Netherlands Sweden

  • Study on the Safety and Effectiveness of GFH925 and Cetuximab for Patients with Advanced Lung Cancer with KRAS G12C Mutation

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Gfh925
    • Cetuximab
    France Greece Italy Spain

  • Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Pd-1
    • Sodium Chloride
    Greece Hungary Italy Poland Spain

  • Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    • Vibostolimab
    Austria Belgium France Germany Ireland Italy +3

  • Study on Atorvastatin for Preventing Episodic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atorvastatin
    • Placebo
    Norway
Previous Page
1 … 891 892 893 894 895 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!